학술논문
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)
Document Type
Article
Author
Ghesquieres, H.; Chevrier, M.; Laadhari, M.; Chinot, O.; Choquet, S.; Moluçon-Chabrot, C.; Beauchesne, P.; Gressin, R.; Morschhauser, F.; Schmitt, A.; Gyan, E.; Hoang-Xuan, K.; Nicolas-Virelizier, E.; Cassoux, N.; Touitou, V.; Le Garff-Tavernier, M.; Savignoni, A.; Turbiez, I.; Soumelis, V.; Houillier, C.; Soussain, C.
Source
In Annals of Oncology April 2019 30(4):621-628
Subject
Language
ISSN
0923-7534